PYRAZOLO [3,4-D]PYRIMIDINES - ADENOSINE RECEPTOR SELECTIVITY

被引:10
作者
CHEBIB, M [1 ]
QUINN, RJ [1 ]
机构
[1] GRIFFITH UNIV,QUEENSLAND PHARMACEUT RES INST,BRISBANE,QLD 4111,AUSTRALIA
基金
英国医学研究理事会;
关键词
D O I
10.1016/0960-894X(95)00420-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Substitution of 1-phenylpyrazolo[3,4-d]pyrimidines at C6 (corresponding to C2 of xanthines/ adenosines) with thioethers containing amide moieties has resulted in compounds with A(1) and A(2a) adenosine receptor selectivity. This further demonstrates that distal moieties can modify receptor selectivity.
引用
收藏
页码:2409 / 2412
页数:4
相关论文
共 18 条
[1]  
BRUNS RF, 1986, MOL PHARMACOL, V29, P331
[2]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[3]  
COLLIS MG, 1993, TRENDS PHARMACOL SCI, V14, P360
[4]   PYRAZOLO[3,4-D]PYRIMIDINES, A NEW CLASS OF ADENOSINE ANTAGONISTS [J].
DAVIES, LP ;
BROWN, DJ ;
CHOW, SC ;
JOHNSTON, GAR .
NEUROSCIENCE LETTERS, 1983, 41 (1-2) :189-193
[5]   PYRAZOLO[3,4-D]PYRIMIDINES AS ADENOSINE ANTAGONISTS [J].
DAVIES, LP ;
CHOW, SC ;
SKERRITT, JH ;
BROWN, DJ ;
JOHNSTON, GAR .
LIFE SCIENCES, 1984, 34 (22) :2117-2128
[6]   THE 3 BINDING DOMAIN MODEL OF ADENOSINE RECEPTORS - MOLECULAR MODELING ASPECTS [J].
DOOLEY, MJ ;
QUINN, RJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (02) :211-216
[7]   ADENOSINE-A1-RECEPTOR AND LIGAND MOLECULAR MODELING [J].
DUDLEY, MW ;
PEET, NP ;
DEMETER, DA ;
WEINTRAUB, HJR ;
IJZERMAN, AP ;
NORDVALL, G ;
VANGALEN, PJM ;
JACOBSON, KA .
DRUG DEVELOPMENT RESEARCH, 1993, 28 (03) :237-243
[8]   SYNTHESIS AND ADENOSINE RECEPTOR AFFINITY OF A SERIES OF PYRAZOLO[3,4-D]PYRIMIDINE ANALOGS OF 1-METHYLISOGUANOSINE [J].
HARDEN, FA ;
QUINN, RJ ;
SCAMMELLS, PJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (09) :2892-2898
[9]  
IJzerman A P, 1992, Drug Des Discov, V9, P49
[10]  
JARVIS MF, 1989, J PHARMACOL EXP THER, V251, P888